Investors English_20120222

Home Investors Press Releases

Press Releases

Title Filter     Display # 
# Article Title Date
1 3SBio Inc. Exclusively Licenses Pegsiticase (Uricase PEG-20) to Selecta Biosciences to Develop Drug Candidate to Treat Gout 18-Jun-2014
2 3SBio to Develop DJ5 for Progressive Renal Failure in ADPKD Patients 29-Oct-2013
3 3SBio Inc. Announces Completion of Merger 30-May-2013
4 3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 24-May-2013
5 3SBio Inc. Announces Extraordinary General Meeting of Shareholders 02-May-2013
6 3SBio Inc. Announces Extraordinary General Meeting of Shareholders 02-May-2013
7 3SBio Inc. Files Annual Report on Form 20-F for Fiscal Year 2012 01-May-2013
8 3SBio Inc. Adjourns Extraordinary General Meeting of Shareholders 25-Apr-2013
9 3SBio Inc. Enters Into Amendment to Merger Agreement For "Going Private" Transaction 24-Apr-2013
10 3SBio Inc. Announces Receipt of Amended "Going Private" Proposal at $16.70 Per ADS and Intent to Adjourn Extraordinary General Meeting of Shareholders 23-Apr-2013
11 3SBio Inc. Announces Extraordinary General Meeting of Shareholders 24-Mar-2013
12 3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2012 Results 18-Mar-2013
13 3SBio Inc. Schedules Unaudited Fourth Quarter and Full Year 2012 Results 03-Mar-2013
14 3SBio Inc. Enters Into Merger Agreement For "Going Private" Transaction 08-Feb-2013
15 3SBio Inc. Announces Unaudited Third Quarter 2012 Results 11-Nov-2012
16 3SBio Inc. Announces Results Of 2012 Annual General Meeting 13-Oct-2012
17 3SBio Inc. Schedules Unaudited Third Quarter 2012 Results 09-Oct-2012
18 3SBio Independent Committee Selects Financial Advisor in Connection with Going Private Proposal 28-Sep-2012
19 3SBio Independent Committee Selects Legal Counsel in connection with Going Private Proposal 17-Sep-2012
20 3SBio Inc. Announces Receipt of "Going Private" Proposal at $15 Per ADS 12-Sep-2012
21 3SBio Inc. to Hold 2012 Annual General Meeting on October 10, 2012 10-Sep-2012
22 3SBio Inc. Announces Unaudited Second Quarter and First Half 2012 15-Aug-2012
23 3SBio Inc. Announces Changes to Its Board of Directors 09-Aug-2012
24 3SBio Inc. Schedules Unaudited Second Quarter 2012 Results 17-Jul-2012
25 3SBio Obtains SFDA Approval to Join Global Phase III Trial for Voclosporin 28-Jun-2012
26 3SBio Inc. To Present at the BofAML HK / China Healthcare Corporate Day 06-Jun-2012
27 3SBio Inc. To Present at the DB Access Asia Conference 2012 27-May-2012
28 3SBio Inc. Announces Unaudited First Quarter 2012 Results 14-May-2012
29 3SBio Inc. Files Annual Report on Form 20-F for Fiscal Year 2011 01-May-2012
30 3SBio Inc. Schedules Unaudited First Quarter 2012 Results 24-Apr-2012
31 3SBio Inc. Announces Changes to its Board of Directors 22-Mar-2012
32 3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2011 Results 09-Mar-2012
33 3SBio and DaVita Collaborate on Dialysis Clinics in Northeastern China 09-Mar-2012
34 3SBio Inc. to Present at the Oppenheimer & Co. 6th Annual China Dragon Conference 07-Feb-2012
35 3SBio Inc. Schedules Unaudited Fourth Quarter and Full Year 2011 Results 04-Feb-2012
36 3SBio Inc. to Present at the UBS Greater China Conference 2012 10-Jan-2012
37 3SBio Inc. to Present at 30th Annual J.P. Morgan Healthcare Conference 05-Jan-2012
38 3SBio Announces Unaudited Third Quarter 2011 Results 11-Nov-2011
39 3SBio Inc. Schedules Unaudited Third Quarter 2011 Results 20-Oct-2011
40 3SBio Inc. to Hold 2011 Annual General Meeting on September 20, 2011 20-Aug-2011
41 3SBio Inc. Announces Unaudited Second Quarter and First Half 2011 Results 16-Aug-2011
42 3SBio Inc. Schedules Unaudited Second Quarter 2011 Results 22-Jul-2011
43 3SBio Inc. Announces SFDA Approval of High-Dose EPIAO 12-Jul-2011
44 3SBio Inc. Announces Unaudited First Quarter 2011 Results 12-May-2011
45 3SBio Inc. Schedules Unaudited First Quarter 2011 Results 04-May-2011
46 3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2010 Results 16-Mar-2011
47 3SBio Inc. Schedules Unaudited Fourth Quarter and Fiscal Year 2010 Results 19-Feb-2011
48 3SBio Inc. Submits Application for NuPIAO Phase I Clinical Trial 12-Feb-2011
49 3SBio Inc. Receives SFDA Approval for TPIAO Label Extension for the Treatment of ITP 25-Jan-2011
50 3SBio Inc. Acquires Worldwide Rights to Pegsiticase From EnzymeRx 29-Nov-2010
51 3SBio Inc. Announces Results of Annual General Meeting 24-Nov-2010
52 3SBio Announces Partial Conversion of Isotechnika Debenture 19-Nov-2010
53 3SBio Inc. Announces Unaudited Third Quarter Results 16-Nov-2010
54 3SBio Inc. Schedules Third Quarter 2010 Unaudited Financial Results 18-Oct-2010
55 3SBio Announces Partial Conversion of Isotechnika Debenture 14-Sep-2010
56 3SBio Announces Investor Conference Schedule 07-Sep-2010
57 3SBio and Isotechnika Pharma Announce Strategic Partnership to Develop and Commercialize Voclosporin in China 24-Aug-2010
58 3SBio Inc. Announces Unaudited Second Quarter Results 18-Aug-2010
59 3SBio Inc. Schedules Second Quarter 2010 Unaudited Financial Results 05-Aug-2010
60 3SBio Inc. Announces Filing of Form 20-F With SEC 28-Jun-2010
61 3SBio Inc. Announces Unaudited First Quarter 2010 Results 16-May-2010
62 3SBio Inc. To Report 2010 First Quarter Unaudited Financial Results on May 16, 2010 11-May-2010
63 3SBio Announces Changes to its Board of Directors 10-Mar-2010
64 3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results 12-Feb-2010
65 3SBio and Ascentage Pharma Form Strategic Alliance to Research, Develop and Commercialize Cancer Therapeutics 12-Feb-2010
66 3SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia 08-Feb-2010
67 3SBio Inc. to Report 2009 Fourth Quarter and Full Year Results on February 11, 2010 26-Jan-2010
68 3SBio Inc. Applies for SFDA Registrational Trial for Feraheme(TM) 08-Jan-2010
69 3SBio Inc. to Hold 2010 Annual General Meeting on October 29, 2010 27-Nov-2009
70 3SBio Inc. Announces Unaudited Third Quarter 2009 Results 13-Nov-2009
71 3SBio Inc. to Report 2009 Third Quarter Earnings on November 12, 2009 28-Oct-2009
72 3SBio Inc. Announces Results of Annual General Meeting 20-Oct-2009
73 3SBio Inc. to Hold 2009 Annual General Meeting on October 12, 2009 07-Sep-2009
74 3SBio Inc. Announces Unaudited Second Quarter 2009 Results 12-Aug-2009
75 3SBio Inc. to Report 2009 Second Quarter Earnings on August 11, 2009 23-Jul-2009
76 3SBio Inc. Announces Unaudited First Quarter 2009 Results 20-May-2009
77 3SBio Inc. Announces Appointment of Ernst & Young Hua Ming as Independent Auditor 05-May-2009
78 3SBio Inc. to Report 2009 First Quarter Earnings on May 19, 2009 04-May-2009
79 3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2008 Results 12-Mar-2009
80 3SBio Inc. Receives Official Recognition as a ‘High-Tech Enterprise’ 05-Mar-2009
81 3SBio Inc. to Report 2008 Fourth Quarter and Full Year Earnings on March 11, 2009 25-Feb-2009
82 3SBio Inc. Appoints Mr. Bo Tan as Chief Financial Officer 09-Feb-2009
83 3SBio Inc. Files for SFDA Approval for TPIAO Label Extension for the Treatment of ITP 20-Jan-2009
84 3SBio Inc. to Present at the Piper Jaffray 20th Annual Health Care Conference 25-Nov-2008
85 3SBio Inc. Announces Preliminary Third Quarter 2008 Results 11-Nov-2008
86 3SBio Inc. Files for SFDA Approval of NuLeusin 10-Nov-2008
87 3SBio Inc. Announces Preliminary Third Quarter 2008 Results 01-Nov-2008
88 3SBio Inc. Schedules 2008 Third Quarter Earnings Release on Monday, November 10, 2008 16-Oct-2008
89 3SBio Inc. Files for SFDA Approval of High-dose (36,000 IU) EPIAO 25-Sep-2008
90 3SBio Inc. to Present at the UBS Global Life Sciences Conference 17-Sep-2008
91 3SBio Inc. Announces Results of Annual General Meeting 15-Sep-2008
92 3SBio Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference 26-Aug-2008
93 3SBio Inc. to Hold Annual General Meeting 21-Aug-2008
94 3SBio Inc. Announces Second Quarter 2008 Results 13-Aug-2008
95 3SBio Inc. Schedules 2008 Second Quarter Earnings Release On Tuesday, August 12, 2008 30-Jul-2008
96 3SBio Inc. Announces Filing of Annual Report on Form 20-F 01-Jul-2008
97 3SBio Inc. to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference 28-May-2008
98 AMAG Pharmaceuticals, Inc. and 3SBio, Inc. Announce Strategic Partnership to Develop and Commercialize Ferumoxytol in China 28-May-2008
99 3SBio Inc. to Present at The Oppenheimer 2nd Annual China Dragon Call Conference 19-May-2008
100 3SBio Inc. Announces First Quarter 2008 Results 15-May-2008
101 3SBio Inc. Schedules 2008 First Quarter Earnings Release on Wednesday, May 14, 2008 29-Apr-2008
102 3SBio Inc. Announces Promotion of David Chen as Chief Operating Officer 20-Mar-2008
103 3SBio Inc. Approves Share Repurchase Program 20-Mar-2008
104 3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 21-Feb-2008
105 3SBio Inc. Announces Change to the Board of Directors 20-Feb-2008
106 3SBio Inc. Schedules 2007 Fourth Quarter and Full Year Earnings Release on Wednesday, February 20, 2008 12-Feb-2008
107 3SBio Inc. to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference 30-Jan-2008
108 3SBio Inc. Announces Appointment of Kevin Sow Peng Teo as Chief Financial Officer 28-Jan-2008
109 3SBio Inc. To Present at the 19th Annual Piper Jaffray Health Care Conference 20-Nov-2007
110 3SBio Inc. Announces Third Quarter 2007 Results 13-Nov-2007
111 3SBio Inc. Schedules 2007 Third Quarter Earnings Release On Tuesday, November 13, 2007 31-Oct-2007
112 3SBio Inc. To Present At The CIBC World Markets 18th Annual Healthcare Conference 29-Oct-2007
113 3SBio Inc. to Hold Annual General Meeting 18-Sep-2007
114 3SBio Inc. to Present at the UBS Global Life Sciences Conference 17-Sep-2007
115 3SBio Inc. Announces Second Quarter 2007 Results 09-Aug-2007
116 3SBio Inc. Schedules 2007 Second Quarter Earnings Release on Wednesday, August 8, 2007 02-Aug-2007
117 3SBio Inc. Announces Filing of Annual Report on Form 20-F 02-Jul-2007
118 3SBio Inc. Schedules 2007 First Quarter Earnings Release on Tuesday, May 1, 2007 27-May-2007
119 3SBio Inc. to Present at the CIBC World Markets China Dragon Call Conference 26-May-2007
120 3SBio Inc. to Present at the UBS Global Generic and Specialty Pharmaceuticals Conference and the Merrill Lynch Pan Asia Rising Stars Conference 07-May-2007
121 3SBio Inc. Announces First Quarter 2007 Results 02-May-2007
122 3SBio Inc. to Present at the 2007 CIBC World Markets Annual Biotechnology & Specialty Pharmaceutical Conference 11-Apr-2007
123 3SBio Inc. Announces Fourth Quarter And Fiscal Year 2006 Results 03-Apr-2007
124 3SBio Inc. Schedules Fourth Quarter and Fiscal Year 2006 Earnings Release on Monday, April 2, 2007 22-Mar-2007